Dual Immunostimulatory Pathway Agonism through a Synthetic Nanocarrier Triggers Robust Anti‐Tumor Immunity in Murine Glioblastoma-Reference-Cited by-同舟云学术

Dual Immunostimulatory Pathway Agonism through a Synthetic Nanocarrier Triggers Robust Anti‐Tumor Immunity in Murine Glioblastoma

Published:2022-12-18 Issue:7 Volume:35 Page:2208782
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Advanced Materials

Author:

Lugani Sophie¹²^ORCID,Halabi Elias A.¹^ORCID,Oh Juhyun¹^ORCID,Kohler Rainer H.¹^ORCID,Peterson Hannah M.¹^ORCID,Breakefield Xandra O.³⁴^ORCID,Chiocca E. Antonio A.⁵^ORCID,Miller Miles A.¹^ORCID,Garris Christopher S.¹^ORCID,Weissleder Ralph¹³⁵⁶^ORCID

Affiliation:

1. Center for Systems Biology Massachusetts General Hospital 185 Cambridge St, CPZN 5206 Boston MA 02114 USA

2. Medical Faculty Heidelberg University Im Neuenheimer Feld 672 69120 Heidelberg Germany

3. Department of Radiology Massachusetts General Hospital and Harvard Medical School 185 Cambridge Street, Suite 5.210 Boston MA 02114 USA

4. Department of Neurology Massachusetts General Hospital and Harvard Medical School 15 Parkman St #835 Boston MA 02114 USA

5. Department of Neurosurgery Brigham and Women Hospital and Harvard Medical School 60 Fenwood Rd 1st Floor Boston MA 02115 USA

6. Department of Systems Biology Harvard Medical School 200 Longwood Ave Boston MA 02115 USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.202208782

Reference65 articles.

1. Treatment of Glioblastoma

2. Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis

3. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

4. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

5. A review of glioblastoma immunotherapy

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. γ‐Butyrolactone Derivatives of MSA‐2 are STING Prodrugs;ChemMedChem;2024-08-05

2. Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy;WIREs Nanomedicine and Nanobiotechnology;2024-07

3. Blood-brain barrier penetrating nanosystems enable synergistic therapy of glioblastoma;Nano Today;2024-06

4. Polyvinylpyrrolidone‐functionalized graphene oxide as a nanocarrier for dual‐drug delivery of quercetin and curcumin against HeLa cancer cells;Journal of Vinyl and Additive Technology;2024-05-13

5. Host-functionalization of macrin nanoparticles to enable drug loading and control tumor-associated macrophage phenotype;Frontiers in Immunology;2024-03-13